Matteo Sarocchi

663 total citations
20 papers, 386 citations indexed

About

Matteo Sarocchi is a scholar working on Cardiology and Cardiovascular Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Matteo Sarocchi has authored 20 papers receiving a total of 386 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cardiology and Cardiovascular Medicine, 7 papers in Oncology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Matteo Sarocchi's work include Chemotherapy-induced cardiotoxicity and mitigation (10 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Cardiac Imaging and Diagnostics (4 papers). Matteo Sarocchi is often cited by papers focused on Chemotherapy-induced cardiotoxicity and mitigation (10 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Cardiac Imaging and Diagnostics (4 papers). Matteo Sarocchi collaborates with scholars based in Italy, United States and Greece. Matteo Sarocchi's co-authors include Paolo Spallarossa, Eleonora Arboscello, Pietro Ameri, Giacomo Tini, Claudio Brunelli, G Ghigliotti, Enrico Adriano, Maurizio Balestrino, Francesco Grossi and Italo Porto and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and British Journal of Haematology.

In The Last Decade

Matteo Sarocchi

19 papers receiving 382 citations

Peers

Matteo Sarocchi
Matteo Sarocchi
Citations per year, relative to Matteo Sarocchi Matteo Sarocchi (= 1×) peers Simone M. Mrotzek

Countries citing papers authored by Matteo Sarocchi

Since Specialization
Citations

This map shows the geographic impact of Matteo Sarocchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matteo Sarocchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matteo Sarocchi more than expected).

Fields of papers citing papers by Matteo Sarocchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matteo Sarocchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matteo Sarocchi. The network helps show where Matteo Sarocchi may publish in the future.

Co-authorship network of co-authors of Matteo Sarocchi

This figure shows the co-authorship network connecting the top 25 collaborators of Matteo Sarocchi. A scholar is included among the top collaborators of Matteo Sarocchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matteo Sarocchi. Matteo Sarocchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ghigliotti, G, et al.. (2025). Practical considerations about management of pulmonary embolism in patients with cancer. Journal of Thrombosis and Thrombolysis. 59(1). 43–54.
2.
Sarocchi, Matteo, Junmin Li, Depei Wu, et al.. (2024). Cardiac effects of deferasirox in transfusion‐dependent patients with myelodysplastic syndromes: TELESTO study. British Journal of Haematology. 204(5). 2049–2056. 3 indexed citations
3.
Tini, Giacomo, Giuliano Tocci, Allegra Battistoni, et al.. (2023). Role of Arterial Hypertension and Hypertension-Mediated Organ Damage in Cardiotoxicity of Anticancer Therapies. Current Heart Failure Reports. 20(1). 56–62. 5 indexed citations
4.
Malfa, Giovanni La, Paolo Spallarossa, Giacomo Tini, et al.. (2021). Cancer Patient With Unusual Dyspnea in the COVID-19 Era. SHILAP Revista de lepidopterología. 3(5). 823–828. 1 indexed citations
5.
Tini, Giacomo, Pietro Ameri, Giulia Buzzatti, et al.. (2021). Diversity of Cardiologic Issues in a Contemporary Cohort of Women With Breast Cancer. Frontiers in Cardiovascular Medicine. 8. 654728–654728. 7 indexed citations
6.
Marzo, Vincenzo De, Gabriele Crimi, Matteo Vercellino, et al.. (2021). Impact of bioprosthetic valve type on peri-procedural myocardial injury and mortality after transcatheter aortic valve replacement. Heart and Vessels. 36(11). 1746–1755. 7 indexed citations
7.
Tini, Giacomo, Alessandra Cuomo, Allegra Battistoni, et al.. (2021). Baseline cardio-oncologic risk assessment in breast cancer women and occurrence of cardiovascular events: The HFA/ICOS risk tool in real-world practice. International Journal of Cardiology. 349. 134–137. 22 indexed citations
8.
Marzo, Vincenzo De, Silvia Dettori, Laura Ambra Nicolini, et al.. (2021). Early infections after successful transcatheter aortic valve replacement are associated with increased short- and long-term mortality: A single-center study. International Journal of Cardiology. 332. 48–53. 3 indexed citations
9.
Marzo, Vincenzo De, Gabriele Crimi, Stefano Benenati, et al.. (2021). BMI and acute kidney injury post transcatheter aortic valve replacement: unveiling the obesity paradox. Journal of Cardiovascular Medicine. 22(7). 579–585. 16 indexed citations
10.
Spallarossa, Paolo, Matteo Sarocchi, Giacomo Tini, et al.. (2020). How to Monitor Cardiac Complications of Immune Checkpoint Inhibitor Therapy. Frontiers in Pharmacology. 11. 972–972. 26 indexed citations
11.
Tini, Giacomo, Matteo Sarocchi, Giuliano Tocci, et al.. (2019). Arterial hypertension in cancer: The elephant in the room. International Journal of Cardiology. 281. 133–139. 51 indexed citations
12.
Spallarossa, Paolo, Giacomo Tini, Matteo Sarocchi, et al.. (2019). Identification and Management of Immune Checkpoint Inhibitor–Related Myocarditis: Use Troponin Wisely. Journal of Clinical Oncology. 37(25). 2201–2205. 40 indexed citations
13.
Sarocchi, Matteo, Eleonora Arboscello, G Ghigliotti, et al.. (2018). Ivabradine in Cancer Treatment-Related Left Ventricular Dysfunction. Chemotherapy. 63(6). 315–320. 8 indexed citations
14.
Sarocchi, Matteo, Matteo Bauckneht, Eleonora Arboscello, et al.. (2018). An increase in myocardial 18-fluorodeoxyglucose uptake is associated with left ventricular ejection fraction decline in Hodgkin lymphoma patients treated with anthracycline. Journal of Translational Medicine. 16(1). 295–295. 43 indexed citations
15.
Sarocchi, Matteo, Francesco Grossi, Eleonora Arboscello, et al.. (2018). Serial Troponin for Early Detection of Nivolumab Cardiotoxicity in Advanced Non-Small Cell Lung Cancer Patients. The Oncologist. 23(8). 936–942. 66 indexed citations
16.
Spallarossa, Paolo, Claudio Brunelli, Eleonora Arboscello, et al.. (2017). Potential cardiac risk of immune‐checkpoint blockade as anticancer treatment: What we know, what we do not know, and what we can do to prevent adverse effects. Medicinal Research Reviews. 38(5). 1447–1468. 24 indexed citations
17.
Rijavec, Erika, Carlo Genova, Matteo Sarocchi, et al.. (2017). P3.02c-077 Cardiac Troponin-I Elevation in Patients with Non-Small Cell Lung Cancer during PD1/PDL1 Inhibition with Nivolumab. Journal of Thoracic Oncology. 12(1). S1324–S1324. 1 indexed citations
18.
Bauckneht, Matteo, Silvia Morbelli, Francesco Fiz, et al.. (2017). A Score-Based Approach to 18F-FDG PET Images as a Tool to Describe Metabolic Predictors of Myocardial Doxorubicin Susceptibility. Diagnostics. 7(4). 57–57. 10 indexed citations
19.
Balestrino, Maurizio, Matteo Sarocchi, Enrico Adriano, & Paolo Spallarossa. (2016). Potential of creatine or phosphocreatine supplementation in cerebrovascular disease and in ischemic heart disease. Amino Acids. 48(8). 1955–1967. 43 indexed citations
20.
Breccia, Massimo, Eleonora Arboscello, Gioia Colafigli, et al.. (2016). Proposal for a tailored stratification at baseline and monitoring of cardiovascular effects during follow-up in chronic phase chronic myeloid leukemia patients treated with nilotinib frontline. Critical Reviews in Oncology/Hematology. 107. 190–198. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026